Adrian Rabin
Lawyers
Filters
Roche $295 million acquisition of LumiraDx's point of care technology platform
We are advising Roche on the acquisition
MSCI acquisition of Fabric RQ
We are advising MSCI on the acquisition
Smith+Nephew acquisition of CartiHeal
We are advising Smith+Nephew on the acquisition
Sealed Air $425 million senior notes offering and concurrent tender offer
The new high-yield notes are due 2031
Newfold Digital Holdings Group $515 million senior secured notes offering
The high-yield notes are due 2028
Immedica Pharma acquisition of pegzilarginase assets from Aeglea
We advised Immedica on the transaction
Korro Bio $117 million private placement
The financing is expected to close immediately prior to the completion of Korro Bio’s merger with Frequency Therapeutics
Oculis Holding $40.25 million debut equity offering
The shares are listed on the Nasdaq Global Market
Seagate HDD Cayman $1 billion senior notes offering
The notes are due 2029 and 2031
Emergent BioSolutions $150 million at-the-market offering
The shares are listed on the NYSE